Time filter

Source Type

Ou J.,Xinjiang Caner Institute and Hospital | Wu T.,Xinjiang Caner Institute and Hospital | Ni D.,Xinjiang Caner Institute and Hospital | Xu W.,Xinjiang Caner Institute and Hospital | And 2 more authors.
Chinese Journal of Clinical Oncology | Year: 2012

Objective: This study aimed to investigate the prevalence and spectrum of the BRCA1/2 gene mutation in high-risk breast cancer cases among multiple ethnic groups in Xinjiang, China. Methods: A total of 68 high-risk breast cancer cases from Xinjiang were included in this study according to the following inclusion criteria: 12 hereditary predisposition to breast cancer (HBC) cases (at least one first- or second-degree relative with breast cancer), 4 hereditary predisposition to breast and ovarian cancer cases (at least one first- or second-degree relative with ovarian cancer), 25 early-onset breast cancer cases (onset age below 35 years), 10 bilateral breast cancer cases, and 17 triple-negative breast cancer cases (onset age below 45 years). Genomic DNA was extracted and relevant coding sequences were amplified by PCR. The entire coding BRCA1/2 genes were analyzed by DHPLC followed by DNA sequencing. Results: A total of six deleterious mutations were identified: three in BRCA1 and three in BRCA2. The prevalence of BRCA1/2 mutation in high-risk HBC was 8.8% (6/68). No significant difference was observed among the ethnic groups in terms of BRCA1/2 mutation prevalence. Conclusion: High-risk HBC cases had different BRCA mutation spectra from ethnic Chinese breast cancer cases in Xinjiang, China.

Loading Xinjiang Caner Institute and Hospital collaborators
Loading Xinjiang Caner Institute and Hospital collaborators